SS Innovations International (NASDAQ: SSII) announced that its SSi Mantra surgical robotic system and SSi MantrAsana tele-surgeon console were used in successful telesurgeries during two international medical conferences in October 2026. The demonstrations underscore the growing viability of remote robotic surgery and its potential to bridge gaps in surgical expertise across geographies.
At the European Association for Cardio-Thoracic Surgery Annual Meeting in Barcelona, Spain, Chairman and CEO Dr. Sudhir Srivastava performed a robotic-assisted cardiac procedure remotely on a patient in Bengaluru, India, approximately 7,500 miles away. This transcontinental procedure highlights the system's ability to enable real-time surgery despite vast distances. At the Society of Robotic Surgery India Conference in New Delhi, four surgeons completed four separate robotic-assisted telesurgeries involving kidney, colorectal, pediatric urological, and gynecological procedures. These diverse cases demonstrate the platform's versatility across multiple surgical specialties.
The SSi MantrAsana console is designed to enable real-time remote surgery through ultra-low latency connectivity, high-definition visualization, and precise instrument control. As of October 23, 2026, a total of 205 telesurgeries, including complex cardiac procedures, had been performed using the SSi Mantra system. This milestone suggests that telesurgery is moving from experimental to routine use, with implications for reducing travel burdens on patients and enabling expert surgeons to operate across borders.
The ability to perform remote surgery has significant implications for healthcare access, particularly in underserved or remote regions where specialized surgical expertise may be scarce. By allowing surgeons to operate on patients located thousands of miles away, telesurgery could help address disparities in surgical care and improve outcomes. SS Innovations aims to make robotic surgery affordable and accessible to a larger segment of the global population, according to the company. The SSi Mantra system has been clinically validated in India for more than 190 different types of surgical procedures.
For more details, the full press release is available at https://ibn.fm/Ujtlm. SS Innovations International is listed on NASDAQ under the ticker SSII, and additional information about the company can be found on SS Innovations International (NASDAQ: SSII). The company's website is ssinnovations.com, and updates are also shared on LinkedIn. The original release is available at www.newmediawire.com.
